Initial dose: 2.5 mg subcutaneously once a week

After 4 weeks: The dosage should be increased to 5 mg subcutaneously once a week.

For additional glycemic control: Increase dosage in 2.5 mg increments after at least 4 weeks on current dose.

Maximum dose: 15 mg subcutaneously once a week.

The 2.5 mg dosage is for treatment initiation and is not intended for glycemic control.

To reduce the risk of hypoglycemia, consider reducing the dose of insulin and/or sulfonylurea when used in combination with this drug.

The day of weekly administration can be changed, if necessary, as long as the time between the 2 doses is at least 3 days (72 hours).

This drug should not be used in patients with type 1 diabetes mellitus.
 
Back
Top